Xiaole Zhu
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Pyruvate Kinase M2-Responsive Release of Paclitaxel and Indoleamine 2,3-Dioxygenase Inhibitor for Immuno-Chemotherapy of Nonsmall Cell Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 16, 2024
Comprehensive analysis of autophagy status and its relationship with immunity and inflammation in ischemic stroke through integrated transcriptomic and single-cell sequencing.
Journal: Genes and immunity
Published: August 04, 2024
The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer.
Journal: Journal of immunology research
Published: November 15, 2022
Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer.
Journal: Frontiers in genetics
Published: July 10, 2022
Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients.
Journal: Digital health
Published: March 22, 2022
CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer.
Journal: Frontiers in oncology
Published: December 09, 2021
Development an Inflammation-Related Factor-Based Model for Predicting Organ Failure in Acute Pancreatitis: A Retrospective Cohort Study.
Journal: Mediators of inflammation
Published: July 22, 2021
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Journal: Medical oncology (Northwood, London, England)
Published: January 17, 2020
Clinical Predictive Factors of Lower Extremity Deep Vein Thrombosis in Relative High-Risk Patients after Neurosurgery: A Retrospective Study.
Journal: Disease markers
Published: November 21, 2019
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 05, 2019
Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 03, 2019
Last Updated: 09/26/2026